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Abstract
Objective
Regular physical activity may be associated with improved lung function via reduced sys-
temic inflammation, although studies exploring this mechanism are rare. We evaluated the
role of C-reactive protein in blood, which is a common marker of systemic inflammation, on
the association of physical activity with forced expiratory volume in one second and forced
vital capacity.
Methods
Cross-sectional data on spirometry, C-reactive protein levels and self-reported physical
activity (yes/no;�2 times and�1hr per week of vigorous physical activity) were available in
the European Community Respiratory Health Survey (N = 2347 adults, 49.3% male, 28–56
years-old). A subsample was also assessed 10 years later using the International Physical
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Activity Questionnaire, and tertiles of Metabolic Equivalent of Task—minutes per week
spent in vigorous, moderate and walking activities were calculated (N = 671, 49.6% male,
40–67 years-old). Adjusted cross-sectional mixed linear regression models and the “medi-
ate” package in “R” were used to assess the presence of mediation.
Results
Despite positive significant associations between nearly all physical activity metrics with
forced expiratory volume in one second and forced vital capacity, there was no evidence
that C-reactive protein levels played a role. An influence of C-reactive protein levels was
only apparent in the smaller subsample when comparing the medium to low tertiles of mod-
erate activity (mean difference [95% CIs]: 21.1ml [5.2, 41.9] for forced expiratory volume in
one second and 17.3ml [2.6, 38.0] for forced vital capacity).
Conclusions
In a population of adults, we found no consistent evidence that the association of physical
activity with forced expiratory volume in one second or forced vital capacity is influenced by
the level of C-reactive protein in blood.
Introduction
The evidence linking regular physical activity and improved lung function is growing and
appears to suggest stronger associations among current smokers [1, 2]. Reduced systemic
inflammation, induced by the anti-inflammatory effects of regular long-term physical activity,
has been proposed as one potential biological pathway [3], but further research into underlying
mechanisms is called for [4].
Several studies have reported inverse associations between self-reported physical activity
and serum C-reactive protein (CRP) levels [5,6], a commonly used systemic inflammation
marker. Higher CRP levels have also been associated with lower lung function and steeper
lung function decline [7, 8]. However, no study has explicitly examined whether regular physi-
cal activity leads to higher lung function via an effect on systemic inflammation.
We previously reported that regular vigorous physical activity was positively associated
with forced expiratory volume in one second (FEV1) and forced vital capacity (FVC) in cur-
rent smokers participating in the multicentre European Community Respiratory Health Sur-
vey (ECRHS) [1]. To continue this work, we here sought to explore underlying mechanisms.
Specifically, we tested the hypothetical role of C-reactive protein levels on the association of
physical activity with FEV1 and FVC (Fig 1). Our results indicate that, despite a plausible
hypothesis based on the scientific literature, there is no consistent evidence to suggest that the
numerous positive associations observed between physical activity and lung function are influ-
enced by changes in CRP levels.
Materials and methods
Study population
Over 18,000 participants were originally recruited into the ECRHS from 30 centers in 14 coun-
tries in 1991–1993 (ECRHS I) using population-based registers (population-based arm), with
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an oversampling of asthmatics (symptomatic arm) [9]. Two follow-ups approximately ten
years apart have since taken place: ECRHS II in 1999–2003 and ECRHS III in 2010–2014.
Extensive lifestyle and health information was collected using questionnaires and during mea-
surements at clinical visits throughout the ECRHS (I-III). The current analysis uses cross-sec-
tional data obtained during the first (ECRHS II) and second (ECRHS III) follow-ups, during
which physical activity and spirometry data were collected [10, 11]. The analysis is limited to
the eight centers that collected data on CRP levels at ECRHS II (Albacete, Barcelona, Galdakao,
Grenoble, Paris, Reykjavik, Tartu and Uppsala) and the three centers that collected data on
CRP levels at ECRHS III (Grenoble, Paris and Uppsala). Ethical approval from the appropriate
ethics committees was obtained by all centers participating in the ECRHS and written consent
was obtained from all participants.
Lung function
Lung function without bronchodilation was assessed according to American Thoracic Society
recommendations at both follow-ups [12]. FEV1 and FVC in absolute values (mL), repeatable
to 150 mL from at least two of a maximum of five correct manoeuvres, were used in this analy-
sis. During the lung function testing, body weight and height were measured by trained
research staff.
CRP levels
Circulating CRP was measured in frozen stored serum samples which had been taken at both
follow-ups, according to standard protocols. Details of the laboratory techniques used in each
country to measure the CRP levels are provided in the Supplementary Material (S1 Appendix).
The CRP data were log-transformed as it followed a log-normal distribution. Afterward, as the
laboratory measurement methods varied across centers, the CRP data were standardized per
measurement laboratory prior to conducting the analyses (i.e. z-scores were calculated per lab-
oratory method) to account for any potential heterogeneity. There were more participants
with CRP data at the first follow-up (ECRHS II; N = 2347, main population, eight centres)
compared to the second follow-up (ECRHS III; N = 671, subsample population, three centres).
Fig 1. How CRP levels may influence the association between physical activity and lung function.
https://doi.org/10.1371/journal.pone.0222578.g001
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Physical activity
At ECRHS II, leisure-time vigorous physical activity data were collected using self-completed
questionnaires (www.ecrhs.org/quests.htm). Participants were asked how often (frequency)
and for how many hours per week (duration) they usually exercised so much that they got out
of breath or sweaty. The responses for frequency were: every day, 4–6 times a week, 2–3 times
a week, once a week, once a month, less than once a month and never. For statistical analyses,
we grouped together the first two categories, the next two categories and the last three catego-
ries. The responses for duration were: 7 hours or more, about 4–6 hours, about 2–3 hours,
about 1 hour, about half an hour and none. For statistical analyses, we grouped together the
first two categories, the next two categories and the last two categories. Furthermore, as previ-
ously done in the ECRHS cohort [1,8], individuals were classified as physically active if they
exercised with a frequency of at least two times per week and for a duration of at least one
hour a week, and non-active otherwise.
In the subsample assessed ten years later (ECRHS III), more detailed physical activity mea-
sures were collected using the self-completed International Physical Activity Questionnaire
(IPAQ-7 short form). The IPAQ collects information on time spent doing physical activity in
the previous week and has been validated previously in multiple international settings and
population groups [13]. Time spent in vigorous, moderate and walking activities, as well as
their sum, was derived and expressed in Metabolic Equivalent of Task (METs)-min per week,
following the official IPAQ scoring protocol (www.ipaq.ki.se). Tertiles of each IPAQ-variable
were calculated and used in the analysis.
Statistical analyses
To test the role of C-reactive protein levels on the association of physical activity with FEV1
and FVC (Fig 1), we first fit a mediator model, where CRP levels are modelled as a function of
physical activity, after adjusting for relevant covariates (sex, age, height, weight, education,
occupation, secondhand smoke exposure, smoking habit and a random intercept for center,
which are the same as used in our previous analysis [1]). Next, we constructed the outcome
model, which models lung function (the outcome) as a function of CRP levels (the mediator),
including the same covariates as used in the mediator model. We used cross-sectional mixed
linear regression to estimate both the mediator and outcome models.
The mediator and outcome models were then incorporated into the “mediation” package
in the statistical program “R”, which estimates the amount of the association between physical
activity and lung function that is occurring through changes in CRP. Specifically, the popula-
tion average causal mediation effect that is occurring through the mediator (i.e. through
changing CRP levels, also referred to as the indirect effect), the population average direct effect
(remaining effect that is not occurring through changes in CRP levels) and the total effect (the
sum of the indirect and direct effects) are calculated using previously developed algorithms
[14]. Confidence intervals around these effect estimates are calculated using a quasi-Bayesian
Monte Carlo method based on normal approximation, which allowed us to determine whether
the estimated effects are statistically significantly different from zero (consistent with no
effect). Further details of the statistical procedures have been published [15].
Sensitivity analyses included (1) stratifying by smoking (never, former, current), body mass
index (< 25 kg/m2; 25–30 kg/m2; > 30 kg/m2) and asthma, (2) excluding weight from the
models (as it could be considered a mediator itself, rather than a confounder), (3) adjusting for
body mass index instead of weight, (4) dichotomizing the CRP data based on the highest quar-
tile (� 75th vs > 75th percentile) as well as excluding the highest 5th percentile of CRP levels
to assess the potential influence of outliers, and finally, (5) testing for potential exposure-
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mediator interactions by inserting an interaction term between CRP levels (as a continuous
variable) and the physical activity parameters in the “mediator model”.
Finally, we calculated E-values for the indirect, direct and total effects, which are a form of
sensitivity analysis which estimates the minimum strength of association that an unmeasured
confounder would need to have with both the exposure (physical activity) and the outcome
(lung function), conditional on the measured covariates, to explain away any observed associa-
tions [16, 17].
Results
Of the 3,640 participants from the eight centers that collected CRP data at ECHRS II, 2,347 had
the required lung function, physical activity (i.e. activity status) and CRP information for analy-
sis (main study population). Compared to participants from the eight centers that collected
CRP information at ECRHS II but who but did not have the required data for analysis (N =
1,293, characteristics described in Table A in S1 Appendix), the 2,347 who were included were
more likely to be male, older, have asthma and be in a management or technical profession.
Of the 1,097 participants from the three centers that collected CRP data at ECRHS III, 671
of those had the necessary information for analysis, including physical activity data derived
using the IPAQ questionnaire (subsample). Compared to participants from the three centers
that collected CRP information at ECRHS III but who but did not have the required data for
analysis (N = 426, characteristics described in Table A in S1 Appendix), the 671 who were
included were more likely to be in a management or technical profession.
The main (N = 2,347) and subsample (N = 671) study population characteristics are pre-
sented in Table 1. A flow chart depicting the overall derivation of the main study population
and subsample is provided in Fig A in S1 Appendix.
There was little indication of a cross-sectional association between the physical activity
parameters and continuous CRP levels (Table B in S1 Appendix). CRP was cross-sectionally
associated with FEV1 and FVC in the main population at ECRHS II (-112.3 ml [-134.2, -90.4]
and -104.3 ml [-129.4, -79.2] per 1 standard deviation increase in log CRP, respectively) and in
the subsample at ECRHS III (-87.4 ml [-127.6, -47.2] and -76.1 ml [-122.7, -28.5] per 1 stan-
dard deviation increase in log CRP, respectively).
Despite positive significant associations between nearly all physical activity metrics with
FEV1 and FVC, there was no consistent evidence for a role of CRP in this association in the
entire main study population or when restricted to current smokers (Table 2).
When using the IPAQ-physical activity variables available in the subsample assessed ten
years later, a role of CRP on the association between physical activity levels and lung function
was only apparent when comparing the second to first tertiles of METs in moderate activity
(mean difference and 95% confidence intervals of 21.1 [5.2, 41.9] ml and 17.3 [2.6, 38.0] ml for
FEV1 and FVC, respectively, Table 3).
All listed sensitivity analyses conducted yielded similar null findings for a role of CRP, and
we found no evidence to suggest the existence of potential mediator-exposure interactions.
Only the removal of weight from the model led to one additional significant mediation associ-
ation when comparing the third to first tertiles of METs in vigorous physical activity in the
subsample (17.5 [1.9, 35.0] ml for FEV1 and 20.5 [3.4, 40.5] ml for FVC, Table 3).
E-values for the observed direct effects of physical activity on lung function suggest that an
unmeasured confounder that was associated with both physical activity and lung function by a
risk ratio of� 1.30 in the main population and> 1.50 in the subsample population, after
adjustment for all observed confounders, could explain away the estimate, but weaker con-
founding could not. For the single indirect effect observed in the subsample (when comparing
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Table 1. Characteristics of the study population.
Characteristic Main study population
(ECRHS II, N = 2,347)
Subsample with IPAQ data
(ECRHS III, N = 671)
n/N or mean % or (SD) n/N or mean % or (SD)
Male sex 1157/2347 49.3 333/671 49.6
Symptomatic study arm of ECRHS cohort 422/2347 18.0 82/671 12.2
Age completed full time education < 17 years 504/2334 21.6 43/670 6.4
17–20 years 732/2334 31.4 213/670 31.8
> 20 years 1098/2334 47.0 414/670 61.8
Age in yearsa 42.7 (7.4) 55.3 (7.1)
Height in cma 170.1 (9.8) 170.2 (9.7)
Weight in kga 74.0 (15.1) 76.2 (15.6)
BMI < 25 kg/m2 1188/2344 50.7 304/669 45.4
25–30 kg/m2 842/2344 35.9 244/669 36.5
> 30 kg/m2 314/2344 13.4 121/669 18.1
Smoking habit Never 1000/2347 42.6 315/671 46.9
Ex-smoker, < 15 pack-years 357/2347 15.2 140/671 20.9
Ex-smoker, > = 15 pack-years 254/2347 10.8 118/671 17.6
Current smoker, < 15 pack-years 279/2347 11.9 30/671 4.5
Current smoker, > = 15 pack-years 457/2347 19.5 68/671 10.1
Secondhand smoke exposure at home or work 1000/2334 42.8 107/671 15.9
Occupation Management/professional/non-manual 754/2347 32.1 338/671 50.4
Technical/professional/non-manual 395/2347 16.8 155/671 23.1
Other non-manual 549/2347 23.4 86/671 12.8
Skilled manual 267/2347 11.4 29/671 4.3
Semi-skilled/unskilled manual 240/2347 10.2 32/671 4.8
Other/unknown 142/2347 6.1 31/671 4.6
Asthma 412/2343 17.6 145/670 21.6
Pre-bronchodilator FEV1 in ml
a 3455.2 (810.1) 2986.5 (748.8)
Pre-bronchodilator FVC in mla 4320.7 (992.4) 4000.6 (977.8)
Physically active � 2 times and� 1 hr per week 856/2344 36.5 - - - -
Physical activity frequency Low (< 1 a month) 976/2347 41.6 - - - -
Medium (1–3 times a week) 1016/2347 43.3 - - - -
High (> 4 times a week) 355/2347 15.1 - - - -
Physical activity duration Low (< 30 minutes) 1013/2344 43.2 - - - -
Medium (1–3 hours) 922/2344 39.3 - - - -
High (> 4 hours) 409/2344 17.4 - - - -
Total physical activity (MET�min/week) First tertile - - - - 193/611 31.6
Second tertile - - - - 228/611 37.3
Third tertile - - - - 190/611 31.1
Vigorous physical activity (MET�min/week) First tertile - - - - 320/665 48.1
Second tertile - - - - 117/665 17.6
Third tertile - - - - 228/665 34.3
Moderate physical activity (MET�min/week) First tertile - - - - 223/646 34.5
Second tertile - - - - 178/646 27.6
Third tertile - - - - 245/646 37.9
(Continued)
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the second to first tertiles of METs in moderate activity), weaker risk ratios with an unknown
confounder would be required to explain away the estimates (E-values were 1.19 for FEV1 and
1.14 for FVC; Table C in S1 Appendix).
Discussion
This study found no consistent evidence to suggest that the association of physical activity on
lung function occurs through changes in CRP levels. Only in the subsample with more detailed
physical activity data was a potential role for CRP identified for moderate physical activity,
Table 1. (Continued)
Characteristic Main study population
(ECRHS II, N = 2,347)
Subsample with IPAQ data
(ECRHS III, N = 671)
n/N or mean % or (SD) n/N or mean % or (SD)
Walking physical activity (MET�min/week) First tertile - - - - 224/633 35.4
Second tertile - - - - 190/633 30.0
Third tertile - - - - 219/633 34.6
BMI = body mass index; ECHRS = European Community Respiratory Health Survey; FEV1 = forced expiratory volume in one second; FVC = forced vital capacity;
IPAQ = International Physical Activity Questionnaire; MET = Metabolic Equivalent of Task; n = number of participants with characteristic; N = total number of
participants available; SD = standard deviation
a The arithmetic mean and standard deviation are presented for these data which were normally distributed
https://doi.org/10.1371/journal.pone.0222578.t001
Table 2. Mean difference [95% confidence intervals] in lung function (ml) per increase in self-reported physical activity in the main study population at ECRHS II
(N = 2347), when restricted to current smokers (N = 736), and when weight is removed from the models.
Physical activity Effect Main modelsa Current smokers b Weight removedc
FEV1 FVC FEV1 FVC FEV1 FVC
Active
Yes vs. no Indirect (via CRP) -1.2 [-10.2, 7.4] -1.7 [-10.3, 6.4] 9.0 [-12.7, 29.2] 5.7 [-14.5, 24.3] -1.0 [-10.5, 8.3] -1.2 [-11.4, 8.7]
Direct (not via CRP) 50.8 [4.9, 90.0] 60.3 [8.6, 105.3] 144.3 [71.7, 224.2] 148.7 [65.2, 240.3] 51.3 [7.8, 95.0] 61.8 [12.4, 111.6]
Total 49.5 [1.6, 91.4] 58.5 [4.4, 106.1] 153.3 [75.4, 238.9] 154.4 [68.0, 248.9] 50.3 [7.0, 95.6] 60.6 [10.6, 111.4]
Frequency
Medium vs. low Indirect (via CRP) -1.0 [-11.0, 8.3] -2.7 [-12.3, 6.0] 3.8 [-16.9, 26.4] 1.3 [-17.7, 22.1] 2.4 [-7.5, 12.3] 1.1 [-9.6, 11.6]
Direct (not via CRP) 19.0 [-27.4, 65.5] 37.3 [-14.6, 89.3] 86.6 [9.2, 168.0] 113.6 [26.4, 205.5] 20.1 [-26.9, 61.7] 41.2 [-12.3, 89.0]
Total 18.0 [-28.6, 65.4] 34.6 [-17.9, 87.6] 90.4 [11.1, 173.5] 114.9 [25.2, 207.0] 22.5 [-26.0, 66.5] 42.2 [-12.8, 92.2]
High vs. low Indirect (via CRP) -3.6 [-17.0, 9.4] -4.3 [-17.1, 8.0] 0.5 [-29.0, 33.9] -2.9 [-30.8, 27.3] -7.1 [-20.9, 6.9] -7.9 [-22.8, 7.1]
Direct (not via CRP) 63.3 [1.1, 124.2] 71.0 [-0.5, 139.1] 126.9 [15.8, 241.5] 92.3 [-36.2, 225.5] 65.5 [4.1, 126.4] 71.9 [2.4, 141.5]
Total 59.7 [-4.5, 120.5] 66.7 [-4.9, 135.5] 127.4 [13.6, 245.2] 89.4 [-38.2, 225.4] 58.4 [-3.8, 121.0] 64.0 [-6.7, 135.2]
Duration
Medium vs. low Indirect (via CRP) -2.3 [-12.5, 7.5] -2.5 [-12.3, 6.6] 6.8 [-14.1, 29.8] 4.6 [-14.2, 26.0] -0.5 [-10.6, 9.6] -0.4 [-11.1, 10.5]
Direct (not via CRP) 41.6 [-5.1, 89.3] 51.3 [-2.2, 105.8] 152.4 [73.1, 233.1] 165.2 [75.8, 258.4] 42.5 [-3.7, 85.6] 53.9 [1.4, 103.1]
Total 39.3 [-7.5, 87.2] 48.9 [-4.7, 103.3] 159.2 [80.4, 240.6] 169.9 [79.9, 261.5] 42.0 [-7.0, 85.7] 53.5 [-1.8, 102.9]
High vs. low Indirect (via CRP) -4.4 [-17.2, 7.9] -3.8 [-15.7, 7.7] -0.6 [-29.1, 31.6] -3.9 [-30.0, 25.0] -4.7 [-17.9, 8.3] -4.5 [-18.7, 9.0]
Direct (not via CRP) 61.2 [2.8, 118.7] 70.2 [3.8, 136.0] 142.6 [35.1, 254.8] 94.7 [-26.9, 221.6] 63.1 [5.6, 120.0] 73.3 [8.7, 138.0]
Total 56.8 [-2.2, 113.7] 66.4 [1.0, 130.2] 141.9 [32.4, 254.1] 90.8 [-31.1, 220.9] 58.4 [0.9, 117.0] 68.8 [3.7, 135.1]
CRP = C-reactive protein; ECHRS = European Community Respiratory Health Survey; FEV1 = forced expiratory volume in one second; FVC = forced vital capacity
a Models are adjusted for sex, age, height, weight, education, occupation, secondhand smoke exposure, smoking habit and include a random intercept for center.
b Models are adjusted for sex, age, height, weight, education, occupation, secondhand smoke exposure and include a random intercept for center.
c Models are adjusted for sex, age, height, education, occupation, secondhand smoke exposure, smoking habit and include a random intercept for center.
https://doi.org/10.1371/journal.pone.0222578.t002
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Table 3. Mean difference [95% confidence intervals] in lung function (ml) per increase in self-reported physical activity in the subsample with IPAQ data at
ECRHS III (N = 671), when restricted to current smokers (N = 98), and when weight is removed from the models.
Physical activity
(IPAQ)
Effect Main modelsa Current smokers b Weight removedc
FEV1 FVC FEV1 FVC FEV1 FVC
Total
T2 vs T1 Indirect (via CRP) 9.7 [-6.3, 27.9] 7.0 [-6.1, 23.4] -22.0 [-93.8, 24.0] -30.2 [-118.5, 33.7] 14.5 [-2.2, 34.3] 13.6 [-3.7, 34.6]
Direct (not via
CRP)
15.1 [-73.5,
108.7]
90.1 [-14.7, 201] 172.6 [-84.5, 453.2] 254.8 [-32.8, 519.4] 15.7 [-73.5,
108.6]
93.1 [-11.8, 203.1]
Total 24.9 [-69.0,
120.4]
97.1 [-9.8, 209.1] 150.7 [-92.3, 426.8] 224.6 [-77.6, 486.4] 30.2 [-57.3,
122.5]
106.7 [2.4, 215.5]
T3 vs T1 Indirect (via CRP) 7.0 [-9.8, 25.8] 7.0 [-6.9, 24.6] -11.9 [-78.1, 31.8] -20.9 [-120.2, 47.7] 14.3 [-4.3, 33.8] 16.3 [-3.0, 38.1]
Direct (not via
CRP)
86.3 [-15.6,
180.1]
176.5 [55.8,
288.1]
284.0 [-10.6, 553.4] 274.7 [-23.9, 565.9] 91.4 [2.5, 182.1] 185.5 [79.0,
294.9]
Total 93.3 [-7.7, 187.7] 183.5 [63.7,
296.8]
272.0 [-18.7, 539.7] 253.8 [-56.5, 563.4] 105.7 [15.1,
202.5]
201.8 [94.3,
316.7]
Vigorous
T2 vs T1 Indirect (via CRP) 6.4 [-11.0, 24.1] 6.0 [-8.6, 23.2] 10.7 [-36.7, 80.8] 19.9 [-46.6, 115.8] 14.6 [-3.2, 35.5] 18.4 [-0.9, 42.2]
Direct (not via
CRP)
24.7 [-73.7,
131.3]
68.3 [-47.6, 193.0] 115.5 [-237.7,
479.9]
251.0 [-119.9,
639.1]
33.0 [-66.6,
139.0]
85.6 [-31.3, 209.2]
Total 31.0 [-71.8,
140.2]
74.3 [-44.5, 199.2] 126.2 [-224.2,
491.9]
271.0 [-97.2, 669.3] 47.6 [-53.8,
151.9]
104.0 [-13.9, 225]
T3 vs T1 Indirect (via CRP) 10.4 [-2.6, 26.9] 9.5 [-1.2, 25.2] 7.8 [-22.8, 50.0] 15.9 [-21.3, 69.5] 17.5 [1.9, 35.0] 20.5 [3.4, 40.5]
Direct (not via
CRP)
100.7 [14.9,
180.0]
140.0 [38.7,
233.6]
210.4 [-18.0, 425.9] 248.0 [15.5, 462.0] 102.1 [26.3,
180.2]
147.4 [57.4,
239.4]
Total 111.1 [25.6,
191.2]
149.5 [48.8,
243.4]
218.2 [-12.2, 429.4] 264.0 [31.9, 479.3] 119.6 [42.2,
200.8]
167.8 [76.5,
264.8]
Moderate
T2 vs T1 Indirect (via CRP) 21.1 [5.2, 41.9] 17.3 [2.6, 38.0] 9.9 [-24.2, 62.6] 15.7 [-45.4, 87.6] 27.4 [9.7, 49.7] 30.6 [10.7, 56.2]
Direct (not via
CRP)
60.8 [-32.7,
161.2]
82.0 [-29.3, 199.3] 152.9 [-102.5,
405.6]
195.9 [-65.8, 450.0] 56.5 [-34.2,
149.8]
80.1 [-27.7, 191.6]
Total 81.9 [-13.7,
179.7]
99.4 [-11.3, 214.0] 162.7 [-83.7, 424.5] 211.6 [-65.5, 466.3] 83.9 [-6.2, 179.4] 110.7 [2.3, 223.8]
T3 vs T1 Indirect (via CRP) 7.9 [-5.5, 24.1] 6.6 [-5.1, 21.8] -12.3 [-72.0, 20.3] -21.1 [-115.1, 35.5] 14.8 [-0.8, 32.3] 16.4 [-0.8, 36.4]
Direct (not via
CRP)
68.5 [-25.3,
152.2]
155.3 [43.8,
255.4]
57.1 [-212.2, 314.2] 122.9 [-151.9,
402.0]
67.6 [-12.2,
150.4]
159.0 [64.0,
257.4]
Total 76.4 [-16.4,
162.6]
161.9 [51.6,
264.6]
44.8 [-225.0, 297.0] 101.8 [-199.0,
389.5]
82.4 [1.8, 169.7] 175.4 [79.5,
277.5]
Walking
T2 vs T1 Indirect (via CRP) 2.5 [-14.6, 19.6] 2.2 [-12.8, 18.4] 3.8 [-26.5, 47.2] 12.9 [-38.9, 80.9] -2.2 [-20.8, 16.1] -2.7 [-23.2, 17.2]
Direct (not via
CRP)
-5.3 [-97.2, 92.2] 5.9 [-101.7, 119.7] 263.3 [-6.8, 536.9] 222.7 [-51.3, 502.8] -7.2 [-97.8, 86.0] -2.0 [-109.3,
109.1]
Total -2.8 [-96.9, 97.8] 8.1 [-100.3, 125.2] 267.1 [1.3, 558.2] 235.5 [-32, 533.3] -9.4 [-99.5, 85.4] -4.7 [-111.3,
105.5]
T3 vs T1 Indirect (via CRP) -1.4 [-19.2, 15.8] -2.1 [-18.7, 13.1] -18.9 [-104, 45.5] -50 [-161.8, 13.8] 0.9 [-18.7, 19.1] -1.5 [-23.2, 18.2]
Direct (not via
CRP)
-1.1 [-97.6, 88.1] -2.6 [-115.7,
102.7]
52.4 [-293.8, 363.8] 44.6 [-308.8, 359.3] 4.1 [-83.5, 94.1] 2.8 [-101.5, 108.7]
Total -2.5 [-97.7, 89.9] -4.7 [-117.5,
103.1]
33.4 [-296.6, 333.3] -5.4 [-335.3, 297.6] 5.0 [-84.3, 100.4] 1.3 [-104.4, 114.0]
CRP = C-reactive protein; ECHRS = European Community Respiratory Health Survey; FEV1 = forced expiratory volume in one second; FVC = forced vital capacity;
IPAQ = International Physical Activity Questionnaire; T1 = first tertile; T2 = second tertile; T3 = third tertile
a Models are adjusted for sex, age, height, weight, education, occupation, secondhand smoke exposure, smoking habit and include a random intercept for center.
b Models are adjusted for sex, age, height, weight, education, occupation, secondhand smoke exposure and include a random intercept for center.
c Models are adjusted for sex, age, height, education, occupation, secondhand smoke exposure, smoking habit and include a random intercept for center.
https://doi.org/10.1371/journal.pone.0222578.t003
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which may represent a true or chance finding. Removing weight from the models did yield
one additional association as evidence for a role of CRP for vigorous physical activity in the
subsample, but this result should be interpreted with caution as it is difficult to conclude
whether this suggests that weight might lie in the causal pathway or that residual confounding
by weight is present.
The current study was motivated by the hypothesis that regular physical activity creates an
anti-inflammatory environment in the long-term [3], which leads to higher lung function. We
chose to use individual-level variations in CRP levels to explore this hypothesis because studies
have shown that higher physical activity is associated with lower CRP levels [5,6] and higher
CRP levels are associated with both lower lung function and steeper lung function decline
[7,8]. Despite this existing literature supporting our choice, CRP levels may not be the ideal
marker as very high values can be observed. However, our results remained consistent in sensi-
tivity analyses in which the CRP data were dichotomized based on the highest quartile (� 75th
vs> 75th percentile) and the highest 5th percentile of CRP levels were excluded.
Given our hypothesis of a role of anti-inflammation, the use of “vigorous physical activity”
in the main population may thus not have been optimal, as this type of activity may be partially
pro-inflammatory. However, we have previously found this type of activity to be consistently
associated with higher lung function [1]. In the subsample, we did have more detailed physical
activity measures available collected using the IPAQ questionnaire, which allowed more mod-
erate anti-inflammatory types of physical activity to be considered. However, these associa-
tions risk being underpowered given the smaller sample size available.
Although we included major confounders in our analyses and tested for potential expo-
sure-mediator interactions, we cannot verify that all assumptions were met regarding residual
confounding (e.g. diet data are missing) [18]. Furthermore, participants included in this study
differed from those for whom some necessary data were missing and this non-random reten-
tion may have affected the effect estimates. Notably, individuals in management or technical
professions were over-represented in both the main and subsample study populations. Addi-
tionally, the directionality of any causal pathway cannot be fully assessed as all associations
tested were cross-sectional due to the limited availability of repeated CRP data within centers.
However, we found no indication that reverse causation may be responsible for the observed
association between physical activity and lung function in a previous longitudinal analysis in
the ECRHS [1].
Despite the aforementioned limitations, this study is the first to examine whether reduced
systemic inflammation underlies the association between increased physical activity and
improved lung function using a mediation analysis. The rather null associations observed
leads us to suggest that future studies should evaluate other biomarkers of systemic inflamma-
tion, such as anti-inflammatory cytokines released from contracting skeletal muscle during
exercise, and include more detailed (type and intensity) and repeated data on physical activity.
Furthermore, other mechanisms should be explored, such as the potential for physical activity
to lead to beneficial changes in body composition and fat distribution and changes in respira-
tory muscle endurance and strength, both of which may affect lung function. A better under-
standing of the underlying biological mechanisms is required to strengthen causal inference
between physical activity and lung function. It will also provide a gateway for developing
informed and effective public health policies.
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